TickerFiles

Benitec Biopharma Inc. 10-Q filing

Filed 2025-11-14 · Report date 2025-09-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001193125-25-283274
Form type
10-Q
CIK
0001808898
Primary document
https://www.sec.gov/Archives/edgar/data/1808898/000119312525283274/d64837d10q.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Benitec Biopharma Inc..

Reported financial metrics

MetricCurrentPriorChange
Revenue$0--
Operating Income$-9.8M--
Net Income$-9.0M--
Eps Basic-0.22--
Eps Diluted-0.22--
Cash And Equivalents$94.5M--
Total Assets$96.0M--
Total Liabilities$2.4M--
Shareholders Equity$93.6M--
Operating Cash Flow$-3.4M--